Skip to main content
. 2019 Mar 31;2019:1438628. doi: 10.1155/2019/1438628

Table 3.

Performance of FOLR1, DHFR, and MTRR in the differential diagnosis drug-resistant cases from ovarian cancer patients.

Groups Sensitivity Specificity Accurate Youden index True positive True negative False positive Flase negative
FOLR1 88.2% 55.2% 76.2% 43.4% 45 16 13 6
DHFR 69.0% 62.7% 65.0% 31.7% 20 32 19 9
MTRR 44.8% 92.2% 75.0% 37.0% 13 47 4 16
FOLR1+DHFR+MTRR 82.1% 84.6% 83.8% 66.8% 23 44 8 5